Product Information
OXCARBAZEPINE 300 MG/5 ML SUSP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1244 per ML under NDC 67877053258. Its NADAC has been published 59 times since May 14, 2025.
Strength
60 mg/mL
Manufacturer
Ascend Laboratories, LLCNDC
67877053258
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA213183On Market Since
1/1/2020
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has been published 59 times since May 14, 2025, and over the history we have for it it has declined 45.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1244 per ML |
|---|---|
| All-time high | $0.2400 (Jun 11, 2025) |
| All-time low | $0.1244 (Jun 17, 2026) |
| 52-week high | $0.2377 |
| 52-week low | $0.1244 |
| Median price | $0.1512 |
| Average price | $0.1666 |
| Largest weekly change | -15.8% (Aug 20, 2025) |
| Weeks tracked | 59 |
| Tracking since | May 14, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Oxcarbazepine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG/5 ML SUSP, manufactured by Ascend Laboratories, LLC, is $0.1244 per ML (NDC 67877053258), effective Jun 24, 2026.
How has the price of OXCARBAZEPINE 300 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has declined 45.8%. It has been tracked across 59 weekly CMS publications since May 14, 2025.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG/5 ML SUSP?
Since May 14, 2025, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has ranged from a low of $0.1244 (Jun 17, 2026) to a high of $0.2400 (Jun 11, 2025), with a median of $0.1512 per ML.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OXCARBAZEPINE 300 MG/5 ML SUSP, so no direct lower-cost alternative is listed.
Who manufactures OXCARBAZEPINE 300 MG/5 ML SUSP?
OXCARBAZEPINE 300 MG/5 ML SUSP (NDC 67877053258) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification